Provided by Tiger Trade Technology Pte. Ltd.

Kura Oncology

10.67
+0.14001.33%
Post-market: 10.670.00000.00%16:42 EDT
Volume:1.10M
Turnover:11.78M
Market Cap:947.22M
PE:-3.17
High:10.99
Open:10.43
Low:10.32
Close:10.53
52wk High:13.90
52wk Low:7.36
Shares:88.77M
Float Shares:70.60M
Volume Ratio:0.62
T/O Rate:1.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.3668
EPS(LYR):-3.1784
ROE:-167.71%
ROA:-31.30%
PB:19.56
PE(LYR):-3.36

Loading ...

Kura Oncology-Backed Caspian Plans Phase 1 Study of Diabetes Drug Candidate KO-7246

Reuters
·
Yesterday

Kura Oncology Grants Inducement Stock Options for 128,250 Shares to Nine New Hires

Reuters
·
Oct 02

Press Release: Kura Oncology Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Dow Jones
·
Oct 02

Kura Oncology Initiated at Overweight by JP Morgan

Dow Jones
·
Oct 01

JPMorgan Initiates Kura Oncology at Overweight With $30 Price Target

MT Newswires Live
·
Oct 01

Kura Oncology initiated with an Overweight at JPMorgan

TIPRANKS
·
Oct 01

Kura Oncology, - Caspian and Kura Announce Ko-7246 as Potential Best-in-Class Menin Inhibitor for Diabetes

THOMSON REUTERS
·
Sep 29

Kura Oncology-Backed Caspian Advances KO-7246 Menin Inhibitor Toward First-in-Human Diabetes Trials

Reuters
·
Sep 29

Kura Oncology CSO Francis Burrows Disposes of Common Shares Worth $224,435.31

Reuters
·
Sep 26

Kura Oncology CFO Jennifer Fulk Files Initial Beneficial Ownership Statement

Reuters
·
Sep 11

Kura Oncology (KURA) Receives a Buy from Leerink Partners

TIPRANKS
·
Sep 10

Kura Oncology Launches Caspian Therapeutics, Targets Clinical Proof-of-Concept for Diabetes Drug KO-7246 After USD 50 Million Financing

Reuters
·
Sep 09

Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes

THOMSON REUTERS
·
Sep 09

Kura Oncology Names Jennifer Fulk Finance Chief

MT Newswires Live
·
Sep 08

Kura Oncology Appoints Jennifer Fulk as New CFO

TIPRANKS
·
Sep 08

Kura Oncology Names Jennifer Fulk Chief Financial Officer

Dow Jones
·
Sep 08

Kura Oncology Appoints Jennifer Fulk as Chief Financial Officer

THOMSON REUTERS
·
Sep 08

Kura Oncology Grants Stock Options for 48,450 Shares to Four New Employees at $12.89 Each

Reuters
·
Sep 04

Kura Oncology Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 04

Kura Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 04